Gain in Quality-adjusted Life-years in Patients with Rheumatoid Arthritis During 1 Year of Biological Therapy: A Prospective Study in Clinical Practice (vol 40, pg 1479, 2013)

被引：0

|

作者：

Linde, L.

Sorensen, J.

Ostergaard, M.

Hetland, Lund M.

机构：

来源：

JOURNAL OF RHEUMATOLOGY | 2013年 / 40卷 / 09期

关键词：

D O I：

10.3899/jrheum.121387.C1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1634 / 1634

页数：1

相关论文

共 9 条

[1] Gain in Quality-adjusted Life-years in Patients with Rheumatoid Arthritis During 1 Year of Biological Therapy: A Prospective Study in Clinical Practice
Linde, Louise
Sorensen, Jan
Ostergaard, Mikkel
Hetland, Merete Lund
[J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (09) : 1479 - 1486
[2] REAL-WORLD QUALITY-ADJUSTED LIFE-YEARS GAINS IN PORTUGUESE PATIENTS WITH RHEUMATOID ARTHRITIS FOLLOWING 1 YEAR OF GOLIMUMAB TREATMENT
Laires, P. A.
Mourao, A. F.
Ribeiro, C.
Borges, J.
Goncalves, M. J.
Bernardes, J. M.
Fernandes, S.
Dezerto, R.
Eusebio, M.
Santos, M. J.
Canhao, H.
[J]. VALUE IN HEALTH, 2016, 19 (07) : A530 - A530
[3] Quality-Adjusted Life-Years Gain and Health Status in Patients with OSAS after One Year of Continuous Positive Airway Pressure Use
Rizzi, Camila F.
Ferraz, Marcos B.
Poyares, Dalva
Tufik, Sergio
[J]. SLEEP, 2014, 37 (12) : 1963 - 1968
[4] COMPARISON OF COST PER QALY (QUALITY-ADJUSTED LIFE YEAR) FOR MAJOR TYPES OF CANCERS, END-STAGE RENAL DISEASE AND RHEUMATOID ARTHRITIS IN TAIWAN: A POPULATION-BASED STUDY DURING 1998-2007
Hung, M. C.
Wang, J. D.
[J]. VALUE IN HEALTH, 2013, 16 (03) : A225 - A225
[5] Three-year prospective study of 3228 clinical BPH patients treated with alfuzosin in General Practice (vol 1, pg 276, 1998)
Lukacs, B
[J]. PROSTATE CANCER AND PROSTATIC DISEASES, 1999, 2 (01) : 53 - 53
[6] Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study (vol 13, pg 517, 2020)
Behrens, Frank
Tony, Hans-Peter
Koehm, Michaela
Schwaneck, Eva C.
Gnann, Holger
Greger, Gerd
Burkhardt, Harald
Schmalzing, Marc
[J]. CLINICAL RHEUMATOLOGY, 2020, 39 (08) : 2491 - 2491
[7] Prediction of Clinical Response After 1 Year of Infliximab Therapy in Rheumatoid Arthritis Based on Disease Activity at 3 Months: Posthoc Analysis of the RISING Study (vol 42, pg 599, 2015)
Takeuchi, T.
Miyasaka, N.
Inui, T.
Yano, T.
Yoshinari, T.
Abe, T.
[J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (05)
[8] Prediction of Clinical Response After 1 Year of Infliximab Therapy in Rheumatoid Arthritis Based on Disease Activity at 3 Months: Posthoc Analysis of the RISING Study (vol 42, pg 599, 2015)
Takeuchi, T.
Miyasaka, N.
Inui, T.
Yano, T.
Yoshinari, T.
Abe, T.
[J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (04)
[9] Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naive Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study) (vol 10, e0145468, 2015)
Izumi, Keisuke
Kaneko, Yuko
Hashizume, Misato
Yoshimoto, Keiko
Takeuchi, Tsutomu
[J]. PLOS ONE, 2016, 11 (03):